Welby

Welby EBITDA per Share

The EBITDA per Share of Welby (4438.T) as of Nov 7, 2026 is -54.72 JPY. In the previous year, EBITDA per Share was -98.52 JPY — a change of -44.46% (higher).

EBITDA per Share

-54.72JPY

YoY

-44.46%

Last updated:

EBITDA per Share of Welby is 2025 -54.72 JPY. EBITDA per Share of Welby was 2024 -98.52 JPY. It decreases by -44.46% higher compared to the previous year.

The Welby EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
20.44 JPY
Jan 1, 2019
-0.61 JPY
Jan 1, 2020
-42.57 JPY
Jan 1, 2021
-16.38 JPY
Jan 1, 2022
7.78 JPY
Jan 1, 2023
-64.20 JPY
Jan 1, 2024
-98.52 JPY
Jan 1, 2025
-54.72 JPY
The Welby EBITDA per Share history
YEAREBITDA per ShareYoY
-54.72JPY-44.46%
-98.52JPY+53.46%
-64.20JPY-925.66%
7.78JPY-147.47%
-16.38JPY-61.52%
-42.57JPY+6,897.17%
-0.61JPY-102.98%
20.44JPY-330.19%
-8.88JPY-44.57%
-16.02JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Welby Stock analysis

What does Welby do? Welby, Inc. generates revenue through its disease solution service, developed for pharmaceutical companies to establish patient health record platforms. The company also offers Welby My Carte, a cloud service supporting self-management of patients' living habits for conditions like diabetes and hypertension. Pharmaceutical companies purchase the disease solution service, while patients and healthcare providers utilize Welby My Carte for managing chronic conditions. The firm focuses on medical field applications, targeting pharmaceutical firms and end-users seeking health management tools. The disease solution service involves creating PHR platforms tailored to pharmaceutical companies' needs, while Welby My Carte provides a direct consumer-facing solution for managing health habits. Pharmaceutical companies are the primary B2B buyers, and patients using the service for diabetes or hypertension management represent the end-user segment. The company's revenue streams are derived from both enterprise contracts and consumer subscriptions for its health management tools. Welby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Welby stock

EBITDA per Share of Welby is -54.72 JPY in 2025.

EBITDA per Share of Welby changed from -98.52 JPY to -54.72 JPY, representing a -44.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Welby since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Welby

All Key Metrics — Welby